News

SID2019: Genoskin validates skin integrity and metabolism at 10 days with Promega Glucose-Glo™ and Lac­tate-Glo™ Assays Genoskin’s team of skin experts will be presenting its latest work at the 77th SID Annual Meeting from May 8 to May 11 in Chicago. To learn more about our live human skin models and R&D services, swing by booth #106. Our Chief CommercialRead more

Genoskin to attend the 77th Annual Meeting of the Society for Investigative Dermatology  The 77th Annual Meeting of the Society for Investigative Dermatology (SID2019) is a knowledge hub that connects a diverse group of senior researchers, clinicians and clinical trainees. The SID Meeting appears as a premier forum for the exchange of knowledge in various disciplines, from Dermatology and ImmunologyRead more

Genoskin presents its subcutaneous injection model HypoSkin® at New Frontiers in 3D Genoskin’s CEO Pascal Descargues, PhD will attend scientific symposium New Frontiers in 3D at the MIT Samberg Center in Cambridge, MA, USA. Take the opportunity to discover our unique subcutaneous injection model through a poster presentation.   Hyposkin®, a unique human skin model to study subcutaneous injection PosterRead more

Genoskin presents unique subcutaneous injection model at SOT Baltimore The Genoskin team spreads its wings: in March, you'll find us at the Society of Toxicology's Annual Meeting in Baltimore, US, where we'll present our new HypoSkin model to test the efficacy and toxicity of subcutaneous injections on live human skin models.   Unique tools to test human skin response to allRead more

Genoskin appoints Eric Merle as first chief commercial officer   Salem, MA. – January 4, 2019 – Genoskin, an innovative provider of ex vivo clinical testing skin models and solutions, announced today the addition of Eric Merle as the company’s first chief commercial officer. The new position will see him take responsibility for all regions in which Genoskin operates. Eric has

Read more

Thank you so much for making this past year outstanding! We look forward to further our partnerships and helping you develop more relevant data for 2019! Best wishes of success. The Genoskin team. To keep up-to-date with Genoskin’s latest news, follow us on Twitter and LinkedIn. You can also contact us to learn more about our activities and services.